Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vera Therapeutics, Inc. (VERA)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 63,770,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Vera Therapeutics is a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Co.'s primary product candidate, atacicept, a self-administered fusion protein that blocks both blisibimod and APRIL, is being evaluated for the treatment of immunoglobulin A nephropathy in a global, randomized, double-blind, placebo-controlled clinical trial. Co. has obtained worldwide, exclusive development and commercial rights from Amplyx Pharmaceuticals, Inc., a wholly owned subsidiary of Pfizer Inc., for MAU868, a potentially monoclonal antibody to treat BK viremia infections.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 250,000 250,000 250,000 411,290
Total Buy Value $5,277,311 $5,277,311 $5,277,311 $10,277,301
Total People Bought 1 1 1 2
Total Buy Transactions 2 2 2 3
Total Shares Sold 0 37,188 287,830 2,335,507
Total Sell Value $0 $1,277,449 $12,025,388 $71,384,100
Total People Sold 0 1 2 8
Total Sell Transactions 0 3 18 30
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 178
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Enright Patrick G   –       •      –    2025-06-24 4 B $22.35 $907,635 I/I 40,607 3,596,593 0.01     -
   Enright Patrick G   –       •      –    2025-06-23 4 B $20.87 $4,369,676 I/I 209,393 3,569,522 0.01     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2025-02-26 4 AS $27.55 $250,882 D/D (9,075) 204,665     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2025-02-21 4 AS $27.89 $296,032 D/D (10,613) 213,740     -
   Turner William D. Chief Development Officer   •       –      –    2025-02-18 4 A $0.00 $0 D/D 22,500 22,500     -
   Johnson David Lee Chief Operating Officer   •       –      –    2025-02-18 4 A $0.00 $0 D/D 26,900 26,900     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2025-02-18 4 A $0.00 $0 D/D 80,750 224,353     -
   Grant Sean CHIEF FINANCIAL OFFICER   •       –      –    2025-02-18 4 A $0.00 $0 D/D 26,900 93,237     -
   Young Joseph R SVP, FINANCE, CHIEF ACCT OFFCR   •       –      –    2025-02-18 4 A $0.00 $0 D/D 10,740 61,946     -
   Brenner Robert Chief Medical Officer   •       –      –    2025-02-18 4 A $0.00 $0 D/D 26,900 27,474     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2025-01-08 4 AS $41.53 $730,535 D/D (17,500) 143,603     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2025-01-08 4 OE $2.90 $50,694 D/D 17,500 145,478     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-12-19 4 OE $2.90 $167,032 D/D 57,661 143,603     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-12-18 4 AS $41.33 $753,680 D/D (17,500) 85,942     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-12-18 4 OE $2.90 $50,694 D/D 17,500 87,817     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-12-11 4 AS $46.91 $821,523 D/D (17,500) 85,942     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-12-11 4 OE $2.90 $50,694 D/D 17,500 86,042     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-11-25 4 AS $47.05 $929,560 D/D (19,375) 85,942     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-11-25 4 OE $2.90 $56,126 D/D 19,375 87,817     -
   Carter Jason S Chief Legal Officer   •       –      –    2024-11-18 4 A $0.00 $0 D/D 53,000 53,000     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-11-13 4 AS $49.00 $1,516,037 D/D (30,625) 85,942     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-11-13 4 OE $2.90 $88,715 D/D 30,625 93,442     -
   Seidenberg Beth C   –       •      –    2024-10-28 4 AS $48.01 $720,493 D/D (15,000) 131,553     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-10-23 4 AS $39.81 $782,610 D/D (19,375) 307,972     -
   Fordyce Marshall PRESIDENT AND CEO   •       •      –    2024-10-23 4 OE $2.90 $56,126 D/D 19,375 311,722     -
  178 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us